molecular oncology

Show results for

Unknown (70044)
Genomics (2103)
Proteomics (338)
Transcriptomics (239)
Metabolomics (31)
Genomic (21)
Models (18)
Other (16)
Clinical (5)
Methylation profiling (4)

Organisms

Homo sapiens (357)
Schizosaccharomyces pombe (314)
Sinorhizobium meliloti BL225C (314)
Sus scrofa domesticus (314)
Saccharomyces cerevisiae (314)
Staphylococcus aureus (314)
Rattus norvegicus (314)
Escherichia coli (314)
Methylohalobius crimeensis 10Ki (314)
Homo sapiens (314)
Shigella flexneri (314)
Allexis (314)
Shigella (314)
Zea mays (314)
Medicago truncatula (314)
Mus musculus (21)
Rattus norvegicus (10)
Canis lupus familiaris (4)
Hevea brasiliensis (2)
Pseudomonas putida S12 (1)
Pseudoalteromonas sp. A2 (1)
Astragalus chrysochlorus (1)
Canna indica (1)
Chenopodium amaranticolor (1)
Boehmeria nivea (1)
Canis lupus (1)
Pasteurella multocida subsp. multocida str. Pm70 (1)
Gallus gallus (1)
Drosophila melanogaster (1)
Mus (1)

Organisms

Homo sapiens (1238)
Mus musculus (401)
Rattus norvegicus (19)
Saccharomyces cerevisiae (12)
Canis lupus familiaris (6)
Danio rerio (3)
Heterocephalus glaber (2)
Drosophila melanogaster (2)
Escherichia coli K-12 (1)
Moringa oleifera (1)
Eublepharis macularius (1)
chemical production metagenome (1)
Synthetic plasmid (1)
Mediterraneibacter gnavus (1)
Physcomitrium patens (1)
Macaca mulatta (1)
Gallus gallus (1)
Bos taurus (1)

Repository

ENA (1973)
pride (314)
biostudies-arrayexpress (149)
EGA (119)
geo (114)
MetaboLights (29)
dbGaP (21)
BioModels (17)
iProX (14)
MassIVE (10)
GPMDB (6)
GNPS (2)
Cell Collective (1)
EVA (1)

Tissue

Cell culture (78)
Epithelial cell (43)
Brain (22)
Lung (18)
B cell (15)
Permanent cell line cell (11)
Bone marrow (10)
Blood (9)
T cell (8)
Blood plasma (8)
Fibroblast (6)
Skin (6)
Colon (6)
Breast cancer cell (5)
Melanocyte (5)
Dendritic cell (5)
HeLa cell (5)
Heart (5)
Liver (5)
Monocyte (4)
Urine (4)
Blood serum (4)
Blood cell (4)
Kidney (4)
Macrophage (4)
Breast epithelial cell (3)
Leukemia cell (3)
Stromal cell (3)
Mammary gland (3)
Bladder (3)

Disease

Breast cancer (32)
Acute leukemia (16)
Colon cancer (13)
Lung cancer (10)
Melanoma (7)
Lymphoma (7)
Not Available (6)
Malignant neoplasm of ovary (6)
Lung adenocarcinoma (6)
Cancer (5)
Non-small cell lung carcinoma (5)
Brain cancer (5)
Disease free (5)
Urinary bladder cancer (4)
Pancreatic cancer (4)
Leukemia (3)
Chronic lymphocytic leukemia (3)
Prostate cancer (3)
Pancreatic ductal adenocarcinoma (3)
Colorectal cancer (2)
Neuroblastoma (2)
High risk B-precurser acute lymphoblastic leukemia (1)
Non-classic glioblastoma (1)
Normal tissue (1)
Normal (1)
Anal Cancer (1)
Colon cancer (1)
Carcinoma, Hepatocellular (1)
Carcinoma (1)
Colorectal Neoplasms (1)

Technology Type

Mass Spectrometry (314)
Shotgun proteomics (144)
Bottom-up proteomics (59)
Data-dependent acquisition (49)
Affinity purification coupled with mass spectrometry proteomics (47)
SWATH MS (27)
Data-independent acquisition (25)
Mass spectrometry (23)
Gel-based experiment (13)
Mass spectrometry assay (5)
Chemical cross-linking coupled with mass spectrometry proteomics (4)
SRM/MRM (3)
NMR spectroscopy (2)
DiaPASEF (2)
All-ion fragmentation (2)
Top-down proteomics (2)
Illumina MiSeq, Illumina HiSeq 2500, ILLUMINA (1)
ABI_SOLID, Illumina HiSeq 2000, Illumina 450K, AB 5500xl Genetic Analyzer, AB 5500 Genetic Analyzer, ILLUMINA (1)
Illumina HiSeq 2500, ILLUMINA (1)
Illumina MiSeq (1)
Mass spectrometry imaging (1)
HDMSE (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (9)
Liquid Chromatography MS - positive - reverse phase (8)
Q Exactive (7)
Instrument (6)
Liquid Chromatography MS - (5)
Illumina HiSeq 4000 (3)
LTQ Orbitrap Discovery (Thermo Scientific) (3)
Liquid Chromatography MS - positive - reverse-phase (3)
Liquid Chromatography MS - negative - hilic (3)
Ion Chef (2)
Ion Torrent S5 XL (2)
LTQ Orbitrap Elite (2)
GCT Premier (Waters) (2)
Bruker (2)
UPLC Q-TOF Premier (Waters) (2)
Gas Chromatography MS - positive (2)
Liquid Chromatography MS - alternating - hilic (2)
Genolab M (1)
10x Chromium Controller (1)
Axon GenePix 4000B scanner (1)
NextSeq 550 (1)
Illumina NovaSeq 6000 (1)
Illumina HiSeq 2000 (1)
NextSeq 500 (1)
Illumina MiSeq (1)
ACQUITY UPLC I-Class (1)
TimsTOF HT (1)
Orbitrap Fusion ETD (1)
TimsTOF Pro 2 (1)
Orbitrap Fusion (1)

Publication Date

2024 (90)
2025 (87)
2026 (74)
2023 (57)
2022 (43)
2021 (39)
2020 (31)
2019 (26)
2016 (24)
2017 (23)
2015 (22)
2012 (21)
2018 (20)
2013 (19)
2009 (19)
2014 (15)
2011 (13)
2010 (10)
2008 (8)
2007 (3)
2006 (1)

UNIPROT ID/AC

P00533 (2)
P62993 (2)
P22681 (2)
Q9UK32 (1)
Q9H665 (1)
O00443 (1)
Q504U8 (1)
P31751 (1)
P05231 (1)
P08887 (1)
P27361 (1)
P62070 (1)
Q07889 (1)
Q02750 (1)
P04049 (1)
P01133 (1)

CHEBI ID

CHEBI:17203 (4)
CHEBI:32816 (4)
CHEBI:17295 (4)
CHEBI:18050 (4)
CHEBI:17895 (4)
CHEBI:30769 (4)
CHEBI:15996 (3)
CHEBI:15713 (3)
CHEBI:17552 (3)
CHEBI:16024 (3)
CHEBI:15422 (3)
CHEBI:17239 (3)
CHEBI:30813 (3)
CHEBI:28842 (3)
CHEBI:17677 (3)
CHEBI:17659 (3)
CHEBI:15354 (3)
CHEBI:16643 (3)
CHEBI:16919 (3)
CHEBI:30915 (3)
CHEBI:28837 (3)
CHEBI:422 (3)
CHEBI:16737 (3)
CHEBI:16857 (3)
CHEBI:17053 (3)
CHEBI:15603 (3)
CHEBI:15971 (3)
CHEBI:16015 (3)
CHEBI:15756 (3)
CHEBI:144829 (2)

Metabolite Name

Creatine (4)
Adenosine (4)
Edetic Acid (3)
Aminocaproic acid (3)
N-Nonanoylglycine (3)
N-Acetylmuramate (3)
Indoleacrylic acid (3)
Dodecanoylcarnitine (3)
Allantoin (3)
L-Lysine (3)
L-Methionine (3)
Isophorone (3)
L-Glutamine (3)
L-Tryptophan (3)
L-Tyrosine (3)
Dihydroxyacetone phosphate (3)
Creatinine (3)
Glyoxylic acid (3)
Linoleic acid (3)
Inosine (3)
Beta-Cortolone (2)
Lepidine E (2)
Elastin (2)
3,5,7-Trimethylepicatechin (2)
Carmustine (2)
DG(PGF1alpha/0:0/i-13:0) (2)
2-Chloro-21H,23H-porphyrin (2)
Minaxolone (2)
Aminodeoxykanamycin (2)
Tris(1,3-dichloro-2-propyl)phosphate (2)

First Public Date

2014 (375)
2024 (242)
2025 (203)
2026 (191)
2023 (163)
2020 (149)
2022 (143)
2017 (113)
2019 (97)
2021 (86)
2018 (74)
2015 (64)
2016 (38)
2013 (35)

Modelling Approach

Ordinary differential equation model (12)
Random forest procedure (1)
Computational model (1)
Delayed differential equation model (1)
Boolean model (1)

Study status

Completed (2)
Withdrawn (1)
Not yet recruiting (1)
Recruiting (1)

Lab affiliation

Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, Netherlands (12)
Department of Oncology-Pathology, Karolinska Institutet, 171 77 Stockholm, Sweden Institute of Molecular and Cell Biology, A*STAR, Singapore 138673, Singapore (6)
Center of Molecular and Cellular Oncology, Yale University (4)
Thoracic Oncology Molecular Medicine Program Moffitt Cancer Center Tampa, FL, USA (4)
Leader of the Molecular and Systems Oncology Team in the Division of Molecular Pathology at The Institute of Cancer Research, London, UK (3)
UHN (3)
Molecular Oncology Chemical Biology and Molecular Medicine Moffitt Cancer Center (3)
Yale University (3)
Dept. Oncology Pathology, Karolinska Institutet, and Scilifelab, Stockholm, Sweden (3)
Molecular Oncology Moffitt Cancer Center Tampa, FL, USA (3)
University of Bordeaux, Inserm, UMR1312, BRIC, BoRdeaux Institute of onCology, 146 Rue Léo Saignat, Bordeaux, F-33076, France. (2)
Department of Molecular and Translational Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology; Warsaw, Poland (2)
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China (2)
Department of Oncology-Pathology, Karolinska Institutet, 171 77 Stockholm, Sweden Institute of Molecular and Cell Biology, A*STAR, Singapore 138673, Singapore (2)
1. University of Victoria Genome BC Proteomics Centre, University of Victoria, Victoria, British Columbia, Canada 2. Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada 3. Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada 4. Gerald Bronfman Department of Oncology, Jewish General Hospital, Montreal, Quebec, Canada (2)
1. Department I of Internal Medicine, Center for Integrated Oncology (CIO), Aachen-Bonn- Cologne-Duesseldorf, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne (UoC), 50937 Cologne, Germany 2. Department of Hematology and Cellular Therapy, University of Leipzig, Leipzig, Germany (2)
Department of Oncology-Pathology, SciLifeLab, Karolinska Institutet (2)
Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Jesse, Sara, Andrew, Abigail, Benjamin and Elizabeth Lurie Professor of Oncology in the Departments of Medicine and Biochemistry and Molecular Genetics. (2)
Lab. Neuro-Oncology and Clinical Cancer Proteomics, Erasmus Medical Center, the Netherlands (2)
Orthoped OncoloOrthopedic Oncology Institute, Department of Orthopedic Surgery, Tangdu Hospital, Fourth Military Medical UniversityInstitute, Department of Orthopedic Surgery, Tangdu HospitalOrthopec (2)
European Institute of Oncology (2)
Department of Oncology-Pathology, Karolinska Institute and Scilifelab, Solna, Sweden (2)
Program for Cancer and Cell Biology, Department of Human Anatomy, Histology and Embryology, School of Basic Medical Sciences; Peking University International Cancer Institute; State Key Laboratory of Molecular Oncology, Peking University Health Science Center, Beijing 100191, China. (2)
1. Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada; 2. University of Victoria Genome BC Proteomics Centre, University of Victoria, Victoria, British Columbia, Canada; 3. Gerald Bronfman Department of Oncology, Jewish General Hospital, Montreal, Quebec, Canada; 4. Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada (2)
Department of Translational Medicine – Hand Surgery, Lund University, Malmö, Sweden (2)
OncoProteomics Laboratory, Dept of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands (2)
Division of Surgery, Oncology, and Pathology, Department of Clinical Sciences. Biomedical Center – Lund University, Solvegatan 19, 223 62, Lund, Sweden (2)
Molecular Oncology Chemical Biology and Molecular Medicine Moffitt Cancer Center & Research Institute, SRB3 12902 Magnolia Drive, Tampa, FL, 33612, USA. (2)
European Institute of Oncology, Milan, Italy (2)
Department of Biochemistry and Molecular and Structural Biology, Jozef Stefen Institute, Jamova cesta 39, 1000, Ljubljana, Slovenia (1)

Keyword

IRDye800 (1)
Light-CT Scanner (1)
Tumour detection (1)
Hyperspectral imaging (1)
Fluorescence (1)
Antibody (1)
Bevacizumab (1)

IsPrivate

False (17)

Submitter Keywords

Immuno-oncology (5)
Oncology (2)
Machine Learning Model (2)
FAIR-AIML (1)

Classification

bacteria (1)

Modification

N6 (4)
4-dinitrophenyl modified residue (1)

Study type

Transcription profiling by array (102)
RNA-seq of coding RNA (14)
Comparative genomic hybridization by array (10)
Transcription profiling by RT-PCR (4)
MicroRNA profiling by array (4)
Methylation profiling by array (4)
Interventional (4)
Genotyping by array (3)
Human - One-color microarray (2)
RNA-seq of coding RNA from single cells (2)
Cell line - One-color microarray (1)
ATAC-seq (1)
ChIP-seq (1)
RNA-seq of total RNA (1)
Observational (1)

Release Date

2022 (8088)
2021 (7572)
2023 (6868)
2025 (6534)
2020 (6048)
2024 (5644)
2019 (4560)
2018 (3943)
2017 (3462)
2016 (3430)
2015 (3130)
2014 (2634)
2013 (1589)
2012 (1355)
2011 (1044)
2026 (911)
2010 (908)
2009 (734)
2008 (520)
2007 (340)
2006 (220)
2005 (164)
2004 (113)
2003 (87)
2002 (73)
2001 (72)
2000 (54)
1999 (35)
1998 (33)
1997 (18)

Location

Syria (1)
Hong Kong (1)
Australia (1)
France (1)

Previous page
1 / 7282
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 7282
Next page

Sort by:

Relevance

Page size

The Polycomb Group Protein Suz12 Is Required for Embryonic Stem Cell Differentiation

Polycomb group (PcG) proteins form multiprotein complexes, called Polycomb repressive complexes (PRCs). PRC2 contains the PcG proteins EZH2, SUZ12, and EED and represses transcription through methylation of lysine (K) 27 of histone H3 (H3). Suz12 is essential for PRC2 activity and its inactivation r...

ORGANISM(S): Mus musculus

2011-08-11 | E-GEOD-31354 | biostudies-arrayexpress

Molecular and functional landscape of malignant serous effusions for precision oncology [MSE_drug_treated]

PRJNA1005930 | ENA

Molecular and functional landscape of malignant serous effusions for precision oncology [MSE_baseline]

PRJNA1005931 | ENA

Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.

Not available

S-EPMC10920993 | biostudies-literature

Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition.

Not available

S-EPMC5989850 | biostudies-literature